AstraZeneca vaccine’s chief investigator backs India’s 12-16 week Covishield dose gap – The Economic Times

Clipped from: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-vaccines-chief-investigator-backs-indias-12-16-week-covishield-dose-gap/articleshow/83640773.cmsSynopsis In an interview with The Wire, Professor Andrew Pollard said the immunization policy in Britain and India should not be compared because of

New Delhi’s trilemma: How India manages its interests in the US-China-Russia game will be one of its toughest challenges

Clipped from: https://timesofindia.indiatimes.com/blogs/toi-editorials/new-delhis-trilemma-how-india-manages-its-interests-in-the-us-china-russia-game-will-be-one-of-its-toughest-challenges/TOI Edit Times of India’s Edit Page team comprises senior journalists with wide-ranging interests who debate and opine on the news and issues of

investment strategy: Don’t try to be the rabbit; tortoise is good enough in this market: Basant Maheshwari – The Economic Times

Clipped from: https://economictimes.indiatimes.com/markets/expert-view/dont-try-to-be-the-rabbit-tortoise-is-good-enough-in-this-market-basant-maheshwari/articleshow/83603746.cmsSECTIONSDon’t try to be the rabbit; tortoise is good enough in this market: Basant MaheshwariLast Updated: Jun 17, 2021, 04:57 PM ISTSynopsis “We are

contrarian opportunities: Top contra fund manager shows weak spots that can bring down this market – The Economic Times

Clipped from: https://economictimes.indiatimes.com/markets/expert-view/top-contra-fund-manager-shows-weak-spots-that-can-bring-down-this-market/articleshow/83606677.cms Chiranjivi ChakrabortyEditor, The Economic TimesSynopsis Good contrarian opportunities can come either from a top-down sectoral perspective or bottom-up company specific issue. Sometimes, an

1 130 131 132 133 134 679